Payden Equity Income Fund Adviser Cl
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PYVAX research report →
Price Chart
About the company
The Payden Equity Income Fund endeavors to deliver both long-term capital appreciation and a consistent level of current income to its investors. Its investment strategy primarily centers on well-established, large-capitalization value stocks, identified by their substantial market value and tendency to offer above-average dividend yields. The fund also diversifies into other equity-related instruments that produce income, such as preferred shares, real estate investment trusts (REITs), and master limited partnerships (MLPs).
- IPO
- 2011
- HQ
- Los Angeles, CA, US
Get TickerSpark's AI analysis on PYVAX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.34B
- P/E
- 6.83
- PEG
- 0.00
- P/S
- 146.07
- P/B
- 0.00
- EV/EBITDA
- 12.28
- Div Yield
- 5.60%
- Gross Margin
- 100.00%
- Op Margin
- 23.83%
- Net Margin
- 1213.69%
- ROE
- 18.38%
- ROIC
- 0.34%
Latest fiscal year · YoY change
- Revenue
- $9.20M-12.3%
- Gross Profit
- $9.20M-12.3%
- Op Income
- $2.19M
- Net Income
- $111.63M+210.0%
- EPS
- $2.77+209.5%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $19.36
- 52W Low
- $16.61
- 50D MA
- $19.03
- 200D MA
- $18.10
- Beta
- 0.79
- RSI (14)
- 50
- Avg Volume
- 0
No earnings-call transcripts are available for PYVAX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 71.01M
- Float Shares
- 0
Our PYVAX coverage
Recent articles, reports, and earnings notes.
No research on PYVAX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PYVAX report →